MicuRx(SH:688373) Shang Hai Zheng Quan Bao·2026-01-09 20:07Core Viewpoint - The announcement details the completion of a share reduction plan by major shareholders of Shanghai Mengke Pharmaceutical Co., Ltd, indicating significant changes in shareholding percentages and compliance with legal regulations [1][6]. Shareholder Basic Situation - Before the reduction plan, Best Idea International Limited held 58,439,004 shares (8.91%), JSR Limited held 30,844,484 shares (4.70%), and GP TMT Holdings Limited held 18,371,317 shares (2.80%). JSR and GP TMT are acting in concert, collectively holding 49,215,801 shares (7.51%) [2]. Implementation Results of the Reduction Plan - The reduction plan announced on September 10, 2025, allowed shareholders to reduce up to 39,336,326 shares (6% of total shares) through market transactions within a specified period from October 9, 2025, to January 8, 2026. The plan has now been fully executed [3]. Changes in Shareholding - As of January 8, 2026, Best Idea reduced its holdings by 6,556,054 shares, bringing its total to 51,882,950 shares (7.91%). JSR reduced its holdings by 2,253,190 shares to 28,591,294 shares (4.36%), while GP TMT reduced its holdings by 1,072,070 shares to 17,299,247 shares (2.64%). The combined holdings of JSR and GP TMT decreased to 45,890,541 shares (7.00%) [4]. Compliance and Execution - The company confirmed that the reduction adhered to relevant laws and regulations, and the actual reduction matched the previously disclosed plan. The reduction was completed within the designated timeframe without any early termination or violations of commitments [6].